Skip to main content

Table 1 Transition probability and utility for the 55-year-old cohort

From: Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients

Parameters

Years

Value (%) (range)

References

Probability

Local Recurrence

0–5

6.5

[22]

6–10

1.84

11–15

0.325

NED to metastasis

0–5

18.1

[23]

6–10

9.2

11–15

5.68

Metastasis to death

0–5

25.9

[18]

6–15

15.6

Normal death

56–60 (age)

3.2

[30]

61–65 (age)

4.7

66–70 (age)

5.8

Death due to lung toxicity

11–15

0.49

[25]

Death due to heart toxicity

11–15

2.6

[25]

Death due to CL breast toxicity

11–15

21.7

[22]

SOC PMRT cardiac toxicity

11–15

5.84

[12]

SOC PMRT CL breast cancer

6–15

1.0

[26]

SOC PMRT lung cancer

11–15

4.4

[27]

Utility

 Cardiac toxicity

11–15

0.85 (0.8–0.9)

[35]

 CL breast cancer

11–15

0.803 (0.708–0.816)

[43]

 Lung cancer

11–15

0.72 (0.57–0.87)

[43, 44]

 Recurrence

0–15

0.85

[18]

 NED to metastasis

0–15

0.62

[18]

  1. NED: no evidence of. CL breast: contralateral breast